Optimize anterior segment precision and elevate surgical outcomes with our comprehensive portfolio of advanced Ophthalmic Viscosurgical Devices (OVDs). Designed to meet the rigid demands of modern cataract and intraocular lens (IOL) surgery, our range features highly purified formulations of both Sodium Hyaluronate (NaHA) and Hydroxypropyl Methylcellulose (HPMC), offering distinct rheological advantages tailored to every surgical preference.

Our premium Sodium Hyaluronate (NaHA) solutions deliver exceptional high zero-shear viscosity and elasticity. Engineered as cohesive OVDs, they create and maintain an expansive, stable anterior chamber workspace under positive vitreous pressure. This provides an optimal anatomical environment for precise capsulorhexis and controlled IOL deployment, before facilitating clean, single-piece removal at the procedure's conclusion.

Complementing this, our Hydroxypropyl Methylcellulose (HPMC) solutions offer superb dispersive characteristics. With lower viscosity under high shear stress and exceptional coating abilities, HPMC creates a resilient, long-lasting macromolecular shield over the fragile corneal endothelium. This adhesive layer effectively isolates sensitive ocular tissues, absorbing ultrasound energy and mitigating mechanical trauma during intense high-flow phacoemulsification.

Every formulation in our portfolio is engineered for optical clarity, ensuring an unobstructed, distortion-free view of the surgical field. Manufactured under stringent regulatory standards, our pyrogen-free, CE-certified OVD syringes guarantee maximum biocompatibility, exceptional safety profiles, and minimized post-operative IOP spikes. Partner with a trusted global exporter to secure highly reliable, clinically proven viscosurgical solutions that enhance surgical safety and redefine patient care worldwide.